ICLR ICON plc Forecast, Technical & Fundamental Analysis
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms... Show more
ICLR is expected to report earnings to $2.54 per share on July 29
Q2'26
Est.
$2.54
Q1'26
Missed
by $0.48
Q4'25
Missed
by $0.11
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.07
The last earnings report on May 27 showed earnings per share of $2.52, missing the estimate of $3.00. With 1.44M shares outstanding, the current market capitalization sits at 13.26B.
A.I. Advisor
published General Information
General Information
a provider of clinical research and development services
A.I.dvisor indicates that over the last year, ICLR has been loosely correlated with RGEN. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ICLR jumps, then RGEN could also see price increases.
ICLR in downward trend: price may decline as a result of having broken its higher Bollinger Band on June 24, 2026
ICLR broke above its upper Bollinger Band on June 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In of the 35 cases the stock fell afterwards. This puts the odds of success at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICLR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 24, 2026. You may want to consider a long position or call options on ICLR as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ICLR just turned positive on June 25, 2026. Looking at past instances where ICLR's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ICLR advanced for three days, in of 314 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 230 cases where ICLR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ICLR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.172) is normal, around the industry mean (12.440). P/E Ratio (48.528) is within average values for comparable stocks, (145.998). ICLR's Projected Growth (PEG Ratio) (0.465) is slightly lower than the industry average of (1.492). ICLR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.008). P/S Ratio (1.347) is also within normal values, averaging (7.264).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICLR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
